Knowledge and Understanding of Information After Taking Decision to Participate or Not in a Randomized Trial of Surgery Vs Radiotherapy Among Patients with Locally Advanced Prostate Cancer - an Observational Study

Overview

Journal Acta Oncol

Date 2025 Jan 29

PMID 39876690

Authors

Yvonne Brandberg

Olof Akre

Mia Bergenmar

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Informed consent from trial participants is mandatory. In a randomized clinical trial, we investigated (1) differences in knowledge and understanding of trial information between patients who participated and those who refrained, (2) differences in perceptions of information, and (3) differences in satisfaction with the information.

Patients: After the decision about participation in the randomized study, 'Surgery versus radiotherapy for locally advanced prostate cancer' (SPCG-15), patients were sent questionnaires ('Quality of Informed Consent', EORTC QLQ-INFO25). Patients were categorized in 'Non-participants' or 'Participants'.

Results And Interpretation: A total of 80 patients (80%) responded, 68% of non-participants and 95% of participants. Between-group differences in knowledge were found for duration of the trial, insurances in the trial, and if the trial intervention had been proven to be superior. Patients had high levels of knowledge (> 80%) regarding the trial aim, that participation implied research, the right to decline, that future patients benefit from research and, of the randomization procedure. Less than 50% responded correctly concerning risks associated with the trial, the unproven nature of the trial and issues about insurances. Non-participants scored lower concerning duration of trial participation, confidentiality of medical records, treatments and procedures in the trial, and experimental nature of treatments. There were no differences regarding satisfaction with information. Non-participants and participants did not differ in satisfaction, or in knowledge and understanding of most aspects of the information. Knowledge levels were low in some areas, and thus, it seems to be room for improvement to fulfill the requirements of informed consent.

References

Rodriguez-Torres E, Gonzalez-Perez M, Diaz-Perez C . Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews. Contemp Clin Trials Commun. 2021; 23:100829. PMC: 8358641. DOI: 10.1016/j.conctc.2021.100829. View

Fletcher C, Flight I, Chapman J, Fennell K, Wilson C . The information needs of adult cancer survivors across the cancer continuum: A scoping review. Patient Educ Couns. 2016; 100(3):383-410. DOI: 10.1016/j.pec.2016.10.008. View

Gul R, Ali P . Clinical trials: the challenge of recruitment and retention of participants. J Clin Nurs. 2010; 19(1-2):227-33. DOI: 10.1111/j.1365-2702.2009.03041.x. View

Mills E, Seely D, Rachlis B, Griffith L, Wu P, Wilson K . Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol. 2006; 7(2):141-8. DOI: 10.1016/S1470-2045(06)70576-9. View

Treweek S, Lockhart P, Pitkethly M, Cook J, Kjeldstrom M, Johansen M . Methods to improve recruitment to randomised controlled trials: Cochrane systematic review and meta-analysis. BMJ Open. 2013; 3(2). PMC: 3586125. DOI: 10.1136/bmjopen-2012-002360. View

Unger J, Hershman D, Till C, Minasian L, Osarogiagbon R, Fleury M . "When Offered to Participate": A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials. J Natl Cancer Inst. 2020; 113(3):244-257. PMC: 7936064. DOI: 10.1093/jnci/djaa155. View

Bergenmar M, Johansson H, Wilking N . Levels of knowledge and perceived understanding among participants in cancer clinical trials - factors related to the informed consent procedure. Clin Trials. 2010; 8(1):77-84. DOI: 10.1177/1740774510384516. View

Bergenmar M, Molin C, Wilking N, Brandberg Y . Knowledge and understanding among cancer patients consenting to participate in clinical trials. Eur J Cancer. 2008; 44(17):2627-33. DOI: 10.1016/j.ejca.2008.08.013. View

Kaur G, Smyth R, Williamson P . Developing a survey of barriers and facilitators to recruitment in randomized controlled trials. Trials. 2012; 13:218. PMC: 3563446. DOI: 10.1186/1745-6215-13-218. View

10.

Arraras J, Greimel E, Sezer O, Chie W, Bergenmar M, Costantini A . An international validation study of the EORTC QLQ-INFO25 questionnaire: an instrument to assess the information given to cancer patients. Eur J Cancer. 2010; 46(15):2726-38. DOI: 10.1016/j.ejca.2010.06.118. View

11.

Lidz C, Appelbaum P, Grisso T, Renaud M . Therapeutic misconception and the appreciation of risks in clinical trials. Soc Sci Med. 2004; 58(9):1689-97. DOI: 10.1016/S0277-9536(03)00338-1. View

12.

Bergenmar M, Johansson H, Wilking N, Hatschek T, Brandberg Y . Audio-recorded information to patients considering participation in cancer clinical trials - a randomized study. Acta Oncol. 2014; 53(9):1197-204. DOI: 10.3109/0284186X.2014.921726. View

13.

Joffe S, Cook E, Cleary P, Clark J, Weeks J . Quality of informed consent: a new measure of understanding among research subjects. J Natl Cancer Inst. 2001; 93(2):139-47. DOI: 10.1093/jnci/93.2.139. View

14.

Joffe S, Cook E, Cleary P, Clark J, Weeks J . Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet. 2001; 358(9295):1772-7. DOI: 10.1016/S0140-6736(01)06805-2. View

15.

Bell J, Balneaves L . Cancer patient decision making related to clinical trial participation: an integrative review with implications for patients' relational autonomy. Support Care Cancer. 2015; 23(4):1169-96. DOI: 10.1007/s00520-014-2581-9. View

16.

Brandberg Y, Johansson H, Bergenmar M . Patients' knowledge and perceived understanding - Associations with consenting to participate in cancer clinical trials. Contemp Clin Trials Commun. 2018; 2:6-11. PMC: 5935834. DOI: 10.1016/j.conctc.2015.12.001. View

17.

Thiessen M, Harris D, Tang P, Bouchal S, Sinclair S . Examining the development of information needs assessment tools for use in the cancer context: A scoping and critical review. Palliat Support Care. 2023; :1-13. DOI: 10.1017/S1478951523001232. View

18.

Grand M, OBrien P . Obstacles to participation in randomised cancer clinical trials: a systematic review of the literature. J Med Imaging Radiat Oncol. 2012; 56(1):31-9. DOI: 10.1111/j.1754-9485.2011.02337.x. View